G. Tomlinson

P. Kapur, D. Rakheja, G. Tomlinson, 2005, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Renal cell carcinoma with translocation (X;1). Further evidence for a cytogenetically defined subtype.

V. Tonk, C. Timmons, G. Tomlinson, 1995, Cancer genetics and cytogenetics.

Maternal pregnancy events and exposures and risk of hepatoblastoma: a Children's Oncology Group (COG) study.

M. Georgieff, G. Tomlinson, J. Ross, 2013, Cancer epidemiology.

Parental infertility, infertility treatment and hepatoblastoma: a report from the Children's Oncology Group.

G. Tomlinson, J. Ross, J. Feusner, 2012, Human reproduction.

Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma

T. Druley, R. Hennekam, S. Plon, 2017, Clinical Cancer Research.

An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer

G. Tomlinson, C. Lewis, D. Euhus, 2006, Breast Cancer Research and Treatment.

Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype–phenotype study in neurofibromatosis type 1

Michael F. Wangler, E. Haan, E. Zackai, 2019, Human mutation.

Small cell undifferentiated variant of hepatoblastoma: Adverse clinical and molecular features similar to rhabdoid tumors

G. Tomlinson, J. Feusner, M. Finegold, 2009, Pediatric blood & cancer.

Children's Oncology Group's 2013 blueprint for research: Rare tumors

C. Rodríguez-Galindo, M. Chintagumpala, G. Tomlinson, 2013, Pediatric blood & cancer.

Mutation Screening and Association Study of the Folylpolyglutamate Synthetase (FPGS) Gene with Susceptibility to Childhood Acute Lymphoblastic Leukemia.

J. Beuten, S. Pakakasama, G. Tomlinson, 2015, Asian Pacific journal of cancer prevention : APJCP.

Genetic mosaicism in normal tissues of Wilms' tumour patients

L. Strong, V. Riccardi, G. Tomlinson, 1993, Nature Genetics.

Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers

Jinbo Chen, F. Couch, O. Olopade, 2014, Breast Cancer Research and Treatment.

Long-term risk of medical conditions associated with breast cancer treatment

L. Strong, J. Berg, C. Isaacs, 2014, Breast Cancer Research and Treatment.

Disparities in Cancer Genetic Testing and Variants of Uncertain Significance in the Hispanic Population of South Texas

I. Jatoi, P. Otto, G. Tomlinson, 2022, JCO oncology practice.

Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium

Yukichi Tanaka, R. Alaggio, I. Leuschner, 2014, Modern Pathology.

Rectal cancer in an 11-year-old girl with hyperplastic polyposis.

N. Winick, G. Tomlinson, D. Keljo, 1999, Journal of pediatric gastroenterology and nutrition.

Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.

C. Muller, D. Euhus, J. Schorge, 2001, Gynecologic oncology.

A case‐control analysis of lymphocytic chromosome 9 aberrations in lung cancer

M. Spitz, J. Minna, Xifeng Wu, 2002, International journal of cancer.

Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias.

D. Proia, K. Foley, F. Giles, 2010, Blood.

Hepatic mesenchymal hamartoma with translocation involving chromosome band 19q13.4: a recurrent abnormality.

D. Rakheja, G. Tomlinson, L. Margraf, 2004, Cancer genetics and cytogenetics.

Ultrastructural, immunocytochemical, and cytogenetic characterization of a large congenital fibrosarcoma.

G. Tomlinson, D. Stewart, N. R. Schneider, 1992, Archives of pathology & laboratory medicine.

Liver tumors in children.

G. Tomlinson, J. Litten, 2008, The oncologist.

Recruitment for Breast Cancer Predisposition Studies in an Underserved African American Population

L. Strong, S. Neuhausen, G. Tomlinson, 2005, The breast journal.

Providing primary care for long-term survivors of childhood acute lymphoblastic leukemia.

G. Tomlinson, K. Oeffinger, D. Eshelman, 2000, Journal of Family Practice.

Reaching high-risk underserved individuals for cancer genetic counseling by video-teleconferencing.

B. Pollock, G. Tomlinson, I. Torres, 2016, The Journal of community and supportive oncology.

Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the National Wilms Tumor Study Group

N. Breslow, R. Macklis, D. Green, 2007, Pediatric blood & cancer.

Polymorphisms in CYP 1 A 1 and Ethnic-Specific Susceptibility to Acute Lymphoblastic Leukemia in Children

B. Pollock, J. Beuten, N. Winick, 2011 .

1 Polymorphisms in CYP 1 A 1 and Ethnic-Specific Susceptibility to Acute Lymphoblastic Leukemia in Children

B. Pollock, J. Beuten, N. Winick, 2011 .

Polymorphisms in CYP1A1 and Ethnic-Specific Susceptibility to Acute Lymphoblastic Leukemia in Children

B. Pollock, J. Beuten, N. Winick, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Familial childhood leukemia cluster with multiple aggressive early-onset hematological malignancies

G. Tomlinson, D. Wall, M. Grimley, 2006, Leukemia & lymphoma.

Outcomes for patients with congenital hepatoblastoma

D. V. von Schweinitz, G. Tomlinson, J. Feusner, 2013, Pediatric blood & cancer.

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group

N. Breslow, R. Macklis, D. Green, 2008, Pediatric blood & cancer.

Extraskeletal myxoid chondrosarcoma as a second malignancy after bone marrow transplantation.

G. Tomlinson, A. Weinberg, V. Aquino, 2003, Medical and pediatric oncology.

Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer.

M. Spitz, J. Minna, W. Hong, 1998, Cancer research.

Searching for microsatellite mutations in coding regions in lung, breast, ovarian and colorectal cancers

J. Minna, A. Gazdar, Xie L Xu, 2001, Oncogene.

Acquired Secondary Events in the Pathogenesis of Hereditary Breast Cancer

G. Tomlinson, 1999 .

Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers

F. Couch, O. Olopade, T. Rebbeck, 2010, Breast Cancer Research and Treatment.

CASE 4. Fibrocystic breast disease in a 16-year-old female with PTEN hamartoma tumor syndrome.

P. Weatherall, A. Leitch, C. Eng, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical, histologic, and genetic features of mesothelioma in a 7‐Year‐old child

J. Hung, G. Tomlinson, V. Saldivar, 2013, Pediatric blood & cancer.

Incidence and clinical relevance of abnormal complete blood counts in long‐term survivors of childhood cancer

G. Tomlinson, K. Oeffinger, G. Buchanan, 2006, Cancer.

Mutations of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors.

O. Delattre, C. Timmons, G. Tomlinson, 2000, Journal of the National Cancer Institute.

Renal Metanephric Adenoma With Previously Unreported Cytogenetic Abnormalities: Case Report and Review of the Literature

D. Rakheja, G. Tomlinson, R. Schultz, 2005, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Advances in Brief Benzo [ fl ] pyrene Diol Epoxide-induced 3 p 21 . 3 Aberrations and Genetic Predisposition to Lung Cancer 1

Xifeng, J. Minna, W. Hong, 2006 .

Validity of Models for Predicting BRCA1 and BRCA2 Mutations

Leif E. Peterson, Giovanni Parmigiani, Li Hsu, 2007, Annals of Internal Medicine.

Activated NOTCH2 is Overexpressed in Hepatoblastomas: An Immunohistochemical Study

D. Rakheja, J. Schiffman, T. Chen, 2011, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Modification of lung cancer susceptibility by green tea extract as measured by the comet assay.

M. Spitz, J. Minna, Xifeng Wu, 2002, Cancer detection and prevention.

Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines.

S. Toyooka, A. Maitra, A. Gazdar, 2002, Cancer research.

Identification of genetic susceptibility to childhood cancer through analysis of genes in parallel.

R. Gibbs, D. Muzny, L. Lewis, 2011, Cancer genetics.

Altered fra/zs-Activational Properties of a Mutated WT1 Gene Product in a WAGR-associated Wilms' liimor1

D. Haber, P. Nisen, G. Tomlinson, 2006 .

Advances in Brief Altered fra / zs-Activational Properties of a Mutated WT 1 Gene Product in a WAGR-associated Wilms ' liimor 1

D. Haber, P. Nisen, G. Tomlinson, 2006 .

The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood.

D. Wetter, J. Minna, J. Tsoh, 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Custodianship of genetic information: clinical challenges and professional responsibility.

G. Tomlinson, B. Haley, L. Robinson, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Myeloperoxidase promotor polymorphism and risk of hepatoblastoma

C. Muller, S. Pakakasama, T. Chen, 2003, International journal of cancer.

Rhabdoid tumors in a shared parental environment

T. Chen, G. Tomlinson, D. Bowers, 2006, Pediatric blood & cancer.

Rhabdoid tumor of the kidney with primitive neuroectodermal tumor of the central nervous system: Associated tumors with different histologic, cytogenetic, and molecular findings

V. Tonk, C. Timmons, G. Tomlinson, 1994, Genes, chromosomes & cancer.

ETV6-NTRK3--Trk-ing the primary event in human secretory breast cancer.

C. Timmons, G. Tomlinson, D. Euhus, 2002, Cancer cell.

BRCAPAP: feasibility of clinical BRCA testing on liquid-based cervical cytology: implications for biomarker development.

R. Ashfaq, C. Muller, J. Schorge, 2004, Cancer Epidemiology, Biomarkers and Prevention.

The CHRNA3 rs578776 Variant is Associated with an Intrinsic Reward Sensitivity Deficit in Smokers

Jeffrey M. Engelmann, Jason D. Robinson, Jennifer A. Minnix, 2013, Front. Psychiatry.

Hepatoblastomas and Other Liver Tumors

G. Tomlinson, Heung Bae Kim, 2009 .

Parental Tobacco and Alcohol Use and Risk of Hepatoblastoma in Offspring: A Report from the Children's Oncology Group

Kimberly J. Johnson, G. Tomlinson, J. Ross, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Cytogenetic evaluation of a large series of hepatoblastomas: Numerical abnormalities with recurring aberrations involving 1q12–q21

E. Douglass, G. Tomlinson, N. Schneider, 2005, Genes, chromosomes & cancer.

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Mads Thomassen, Stephen Fox, Dieter Niederacher, 2011, Breast Cancer Research.

RNA expression of the WT1 gene in Wilms' tumors in relation to histology.

L. Strong, C. Timmons, G. Tomlinson, 1992, Journal of the National Cancer Institute.

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

Kenichi Harada, Charles F Timmons, John D Minna, 2002, Oncogene.

WTAP is a novel oncogenic protein in acute myeloid leukemia

G E Tomlinson, U. Suresh, L. Penalva, 2014, Leukemia.

Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer

Olufunmilayo I. Olopade, James Fackenthal, Soma Das, 2000, Human Genetics.

Characterization of paired tumor and non‐tumor cell lines established from patients with breast cancer

M. Westerfield, J. Minna, I. Wistuba, 1998, International journal of cancer.

Discovery of mutations in homologous recombination genes in African-American women with breast cancer

E. John, S. Neuhausen, G. Tomlinson, 2018, Familial Cancer.

BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.

G E Tomlinson, G. Tomlinson, S S Yuan, 1999, Cancer research.

Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups

D. Wheeler, Pavel Sumazin, L. Treviño, 2017, Hepatology.

AURKA F31I Polymorphism and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Consortium of Investigators of Modifiers of BRCA1/2 Study

R. Vierkant, T. Sellers, V. Pankratz, 2007, Cancer Epidemiology Biomarkers & Prevention.

AURKA F 31 I Polymorphism and Breast Cancer Risk in BRCA 1 and BRCA 2 Mutation Carriers : A Consortium of Investigators of Modifiers of BRCA 1 / 2 Study

R. Vierkant, T. Sellers, J. Olson, 2007 .

Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant β-catenin.

Kathryn A. O’Donnell, R. Hammer, D. Rakheja, 2016, JCI insight.

Hypomethylation and hypermethylation of DNA in Wilms tumors

P. Laird, M. Widschwendter, M. Ehrlich, 2002, Oncogene.

Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells

Luzhe Sun, A. Elkahloun, G. Tomlinson, 2012, Molecular biology of the cell.

Germline mutations in PALB2 in African-American breast cancer cases

E. John, S. Neuhausen, G. Tomlinson, 2011, Breast Cancer Research and Treatment.

Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.

J. Minna, A. Gazdar, I. Wistuba, 1998, Cancer research.

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Dieter Niederacher, Ute Hamann, Alfons Meindl, 2008, American journal of human genetics.

RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.

F. Couch, O. Olopade, T. Rebbeck, 2007, American journal of human genetics.

Characterization of BRCA1 and BRCA2 mutations in a large United States sample.

Leif E. Peterson, Giovanni Parmigiani, Christopher I Amos, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood

W. Foulkes, D. Evans, K. Nathanson, 2017, Clinical Cancer Research.

Cytogenetics of a renal cell carcinoma in a 17-month-old child. Evidence for Xp11.2 as a recurring breakpoint.

C. Timmons, P. Nisen, G. Tomlinson, 1991, Cancer genetics and cytogenetics.

Advances in Brief Characterization of a Breast Cancer Cell Line Derived from a GermLine BRCA 1 Mutation Carrier 1

Arvind, Joanne, Monique, 1998 .

Candidate gene association analysis of acute lymphoblastic leukemia identifies new susceptibility locus at 11p15 (LMO1).

B. Pollock, J. Beuten, N. Winick, 2011, Carcinogenesis.

A high-content morphological screen identifies novel microRNAs that regulate neuroblastoma cell differentiation

A. Pertsemlidis, U. Suresh, Yidong Chen, 2014, Oncotarget.

Familial cancer syndromes and genetic counseling.

G. Tomlinson, 1997, Cancer treatment and research.

Satellite DNA hypomethylation in karyotyped Wilms tumors.

Christian B. Woods, N. Hopkins, M. Ehrlich, 2003, Cancer genetics and cytogenetics.

Two identical triplet sisters carrying a germline BRCA1 gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome

J. Minna, I. Wistuba, A. Gazdar, 2000, Genes, chromosomes & cancer.

BRCA1 Expression Restores Radiation Resistance in BRCA1-defective Cancer Cells through Enhancement of Transcription-coupled DNA Repair*

R. Jensen, G. Tomlinson, Derek W. Abbott, 1999, The Journal of Biological Chemistry.

Translocation (10;17)(q22;p13): a recurring translocation in clear cell sarcoma of kidney.

D. Rakheja, G. Tomlinson, A. Weinberg, 2004, Cancer genetics and cytogenetics.

The Transcription Factor Wilms Tumor 1 Confers Resistance in Myeloid Leukemia Cells against the Proapoptotic Therapeutic Agent TRAIL (Tumor Necrosis Factor α-related Apoptosis-inducing Ligand) by Regulating the Antiapoptotic Protein Bcl-xL*

G. Tomlinson, M. Rao, S. Iyer, 2012, The Journal of Biological Chemistry.

Aberrant methylation of the HIC1 promoter is a frequent event in specific pediatric neoplasms.

A. Maitra, A. Gazdar, A. Virmani, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Von Hippel–Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood

K. Nathanson, J. Schiffman, G. Tomlinson, 2017, Clinical Cancer Research.

Multilocus Association of Genetic Variants in MLL, CREBBP, EP300, and TOP2A with Childhood Acute Lymphoblastic Leukemia in Hispanics from Texas

B. Pollock, J. Beuten, N. Winick, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Rosalind Eeles, Susan L Neuhausen, Fergus J Couch, 2010, JAMA.

Potential Susceptibility Markers For Lung Cancer -Radiation-induced G2 Delay, Apoptosis, and p53 Response as γ

M. Spitz, G. Tomlinson, Hua Zhao, 2013 .

γ-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer

M. Spitz, J. Minna, Xifeng Wu, 2001 .

Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group.

N. Breslow, R. Macklis, D. Green, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetics and epigenetics of hepatoblastoma

G. Tomlinson, R. Kappler, 2012, Pediatric blood & cancer.

Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.

J. Minna, A. Gazdar, I. Wistuba, 1997, Cancer research.

Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation

S. Plon, Angshumoy Roy, G. Tomlinson, 2019, Pediatric blood & cancer.

Evidence for Common Ancestral Origin of a Recurring BRCA1 Genomic Rearrangement Identified in High-Risk Hispanic Families

G. Tomlinson, T. Scholl, J. Weitzel, 2007, Cancer Epidemiology Biomarkers & Prevention.

Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis.

L. Strong, H. Anton-Culver, D. Finkelstein, 2008, Cancer research.

7 q 31 : A Genome-Wide Analysis Common Familial Colorectal Cancer Linked to Chromosome

L. Strong, H. Anton-Culver, D. Finkelstein, 2008 .

Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes.

F. Couch, O. Olopade, T. Rebbeck, 2011, Cancer research.

A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers

W. Chung, V. Pankratz, F. Couch, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Genetic Variation in IGF 2 and HTRA 1 and Breast Cancer Risk among BRCA 1 and BRCA 2 Carriers

F. Couch, O. Olopade, T. Rebbeck, 2011 .

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.

O. Olopade, T. Rebbeck, R. Eeles, 2006, The Lancet. Oncology.

Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor.

N. Breslow, D. Green, G. Tomlinson, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.

F. Couch, O. Olopade, T. Rebbeck, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetic predisposition and screening in pediatric cancer.

S. Pakakasama, G. Tomlinson, 2002, Pediatric clinics of North America.

Prevalence of pathogenic germline cancer risk variants in testicular cancer patients: Identifying high risk groups.

G. Sonpavde, Shan Yang, G. Tomlinson, 2022, Urologic oncology.

A subset of cranial fasciitis is associated with dysregulation of the Wnt/β-catenin pathway

D. Rakheja, G. Tomlinson, A. Weinberg, 2008, Modern Pathology.

Multiple coagulation defects and the Cohen syndrome

Golder N Wilson, G. Tomlinson, L. Waber, 1994, Clinical genetics.

Bloom syndrome in a Mexican American family with rhabdomyosarcoma: evidence of a Mexican founder mutation

Yidong Chen, G. Tomlinson, T. DeNapoli, 2021, Cold Spring Harbor molecular case studies.

Congenital abnormalities and hepatoblastoma: A report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB)

M. Georgieff, J. Schiffman, K. Curtin, 2014, American journal of medical genetics. Part A.

Abstract 3774: Congenital abnormalities and hepatoblastoma: A report from the Children's Oncology Group (COG)

M. Georgieff, G. Tomlinson, J. Ross, 2010 .

Examining access to care in clinical genomic research and medicine: Experiences from the CSER Consortium

L. Hindorff, B. Wilfond, Julianne M. O’Daniel, 2021, Journal of Clinical and Translational Science.

Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.

N. Breslow, R. Macklis, D. Green, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood

K. Nathanson, K. Pajtler, J. Schiffman, 2017, Clinical Cancer Research.

MDM2 promoter variation and age of diagnosis of acute lymphoblastic leukemia

G. Tomlinson, B. A. Hirschman, R. Swinney, 2005, Leukemia.

Comparative genomic hybridization analysis of hepatoblastomas: additional evidence for a genetic link with Wilms tumor and rhabdomyosarcoma

G. Tomlinson, M. Steenman, A. Westerveld, 1999, Cytogenetic and Genome Research.

Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer.

M. Spitz, J. Minna, G. Tomlinson, 2001, Cancer research.

Highly aggressive thoracic desmoid tumors in adolescent siblings with fatal outcomes in an FAP kindred: a need for increased vigilance and intervention in at-risk AYAs

G. Tomlinson, M. Gad, A. Langevin, 2020, Familial Cancer.

Highly aggressive thoracic desmoid tumors in adolescent siblings with fatal outcomes in an FAP kindred: a need for increased vigilance and intervention in at-risk AYAs

G. Tomlinson, M. Gad, A. Langevin, 2020, Familial Cancer.

Defining function of wild-type and patient specific TP53 mutations in a zebrafish model of embryonal rhabdomyosarcoma

P. Houghton, G. Tomlinson, D. Libich, 2021, bioRxiv.

Utilizing signature-score to identify oncogenic pathways of cholangiocarcinoma.

Charles Keller, Tzu-Hung Hsiao, Jo-Yang Lu, 2013, Translational cancer research.

Bladder Cancer Incidence and Survival in the United States and Texas Non-Latino Whites and Latinos

J. Michalek, A. Ramirez, R. Mesa, 2020, Bladder Cancer.

Genomic Loss of Tumor Suppressor miRNA-204 Promotes Cancer Cell Migration and Invasion by Activating AKT/mTOR/Rac1 Signaling and Actin Reorganization

A. Pertsemlidis, R. Broaddus, Yidong Chen, 2012, PloS one.

Aberrant methylation of HIN‐1 (high in normal‐1) is a frequent event in many human malignancies

S. Toyooka, A. Gazdar, B. Czerniak, 2005, International journal of cancer.

Genetic markers for treatment-related pancreatitis in a cohort of Hispanic children with acute lymphoblastic leukemia

Yidong Chen, G. Tomlinson, C. Aguilar, 2020, Supportive Care in Cancer.

The first recurring chromosome translocation in hepatoblastoma: Der(4)t(1;4)(q12;q34)

E. Douglass, G. Tomlinson, N. Schneider, 1997, Genes, chromosomes & cancer.

PCR detection of a Bg/II RFLP at 11p13

L. Strong, D. Compton, G. Tomlinson, 1991 .

Phase I study of oral cyclophosphamide and oral topotecan for children with recurrent or refractory solid tumors

P. Leavey, N. Winick, G. Tomlinson, 2004, Pediatric blood & cancer.

WTAP is a novel oncogenic protein in acute myeloid leukemia

U. Suresh, L. Penalva, D. Proia, 2014, Leukemia.

The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities

R. Mesa, G. Tomlinson, Z. Su, 2020, JMIR cancer.

Modification of BRCA 1-Associated Breast and Ovarian Cancer Risk by BRCA 1-Interacting Genes

F. Couch, O. Olopade, T. Rebbeck, 2011 .

Integrity of the pheochromocytoma susceptibility TMEM127 gene in patients with pediatric malignancies.

P. Dahia, G. Tomlinson, K. Janeway, 2015, Endocrine-related cancer.

Cardiovascular Risk Factors in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia

M. Denke, G. Tomlinson, K. Oeffinger, 2001, Journal of pediatric hematology/oncology.

The risk of cancer in twins: A report from the childhood cancer survivor study

L. Strong, L. Robison, T. Kawashima, 2006, Pediatric blood & cancer.

The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms

Jason D. Robinson, Jennifer A. Minnix, Cho Y. Lam, 2007, The Pharmacogenomics Journal.

Phase I and Phase II Enzyme Polymorphisms and Childhood Cancer

G. Tomlinson, R. Swinney, S. Hsu, 2006, Journal of Investigative Medicine.

Childhood acute lymphoblastic leukemia with both t(1;19) and t(9;22).

C. Timmons, A. Carroll, G. Tomlinson, 1992, Leukemia.

TP53 mutation and haplotype analysis of two large African American families

L. Strong, J. Hung, C. Harvey, 1999, Human mutation.

Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.

Nandita Mitra, Georgia Chenevix-Trench, Susan L Neuhausen, 2009, Cancer research.

Activating mutation in MET oncogene in familial colorectal cancer

L. Strong, H. Anton-Culver, D. Ahnen, 2011, BMC Cancer.

The serotonin transporter gene and startle response during nicotine deprivation

Jason D. Robinson, Jennifer A. Minnix, Cho Y. Lam, 2011, Biological Psychology.

Binding of CtIP to the BRCT Repeats of BRCA1 Involved in the Transcription Regulation of p21 Is Disrupted Upon DNA Damage*

C. Osborne, P. L. Chen, W. Lee, 1999, The Journal of Biological Chemistry.

Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers

C. Boland, C. Amos, W. Chen, 2015, Familial Cancer.

RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers.

O. Olopade, J. Minna, Xian-Jin Xie, 2008, Cancer research.

Childhood cancer survival in the highly vulnerable population of South Texas: A cohort study

Melanie A. Williams, Yanning Liu, G. Tomlinson, 2022, medRxiv.

Successful Strategies for Increasing African American Participation in Cancer Genetic Studies: Hopeful Signs for Equalizing the Benefits of Genetic Medicine

G. Tomlinson, Smita K. Rao, P. Banerji, 2008, Public Health Genomics.

Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.

D. Haber, P. Nisen, G. Tomlinson, 1993, Cancer research.

The glycine 90 to aspartate alteration in the Aβ subunit of PP2A (PPP2R1B) associates with breast cancer and causes a deficit in protein function

Edward D Esplin, G. Evans, M. Mumby, 2006, Genes, chromosomes & cancer.

Sorafenib, gamma-secretase inhibitor, and bortezomib as potential therapeutic agents for hepatoblastoma.

J. Hung, T. Chen, G. Tomlinson, 2010 .

Maternal and paternal occupational exposures and hepatoblastoma: results from the HOPE study through the Children’s Oncology Group

Amanda E. Janitz, G. Tomlinson, G. Ramachandran, 2017, Journal of Exposure Science and Environmental Epidemiology.

Rapid, nonradioactive screening for mutations in exons 10, 11, and 16 of the RET protooncogene associated with inherited medullary thyroid carcinoma.

S. Thibodeau, G. Tomlinson, D. Dawson, 1997, Clinical chemistry.

Clinically relevant changes in family history of cancer over time.

L. Strong, A. Ziogas, H. Anton-Culver, 2011, JAMA.

Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.

F. Couch, B. Weber, A. Gazdar, 1998, Molecular cell.

FGF19 functions as autocrine growth factor for hepatoblastoma

Yidong Chen, S. Weintraub, Y. Shiio, 2016, Genes & cancer.

Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study

R. Gibbs, Jianhong Hu, S. Plon, 2023, Pediatric hematology and oncology.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

V. Pankratz, F. Couch, O. Olopade, 2010, Cancer research.

Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers

F. Couch, O. Olopade, T. Rebbeck, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Null Results in Brief Common Genetic Variation at BARD 1 Is Not Associated with Breast Cancer Risk in BRCA 1 or BRCA 2 Mutation Carriers

O. Olopade, T. Rebbeck, R. Eeles, 2011 .

Erratum to: Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers

D. Chaussabel, C. Amos, W. Chen, 2015, Familial Cancer.

Von Hippel–Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood

K. Nathanson, J. Schiffman, G. Tomlinson, 2017, Clinical Cancer Research.

Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias.

D. Proia, K. Foley, F. Giles, 2010, Blood.

Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.

F. Couch, O. Olopade, T. Rebbeck, 2009, Cancer research.

Discovery of mutations in homologous recombination genes in African-American women with breast cancer

E. John, S. Neuhausen, G. Tomlinson, 2017, Familial Cancer.

Analysis of possible abnormal WT1 RNA processing in primary Wilms tumors

L. Strong, G. Tomlinson, S. Cohn, 1996 .